Circuitry of nuclear factor κB signaling

被引:756
作者
Hoffmann, A
Baltimore, D
机构
[1] Univ Calif San Diego, Dept Chem & Biochem, Signaling Syst Lab, La Jolla, CA 92093 USA
[2] CALTECH, Div Biol, Pasadena, CA 91125 USA
关键词
D O I
10.1111/j.0105-2896.2006.00375.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Over the past few years, the transcription factor nuclear factor (NF)-kappa B and the proteins that regulate it have emerged as a signaling system of pre-eminent importance in human physiology and in an increasing number of pathologies. While NF-kappa B is present in all differentiated cell types, its discovery and early characterization were rooted in understanding B-cell biology. Significant research efforts over two decades have yielded a large body of literature devoted to understanding NF-kappa B's functioning in the immune system. NF-kappa B has been found to play roles in many different compartments of the immune system during differentiation of immune cells and development of lymphoid organs and during immune activation. NF-kappa B is the nuclear effector of signaling pathways emanating from many receptors, including those of the inflammatory tumor necrosis factor and Toll-like receptor superfamilies. With this review, we hope to provide historical context and summarize the diverse physiological functions of NF-kappa B in the immune system before focusing on recent advances in elucidating the molecular mechanisms that mediate cell type-specific and stimulus-specific functions of this pleiotropic signaling system. Understanding the genetic regulatory circuitry of NF-kappa B functionalities involves system-wide measurements, biophysical studies, and computational modeling.
引用
收藏
页码:171 / 186
页数:16
相关论文
共 93 条
  • [81] Regulation of the transcriptional activity of the nuclear factor-κB p65 subunit
    Vermeulen, L
    De Wilde, G
    Notebaert, S
    Vanden Berghe, W
    Haegeman, G
    [J]. BIOCHEMICAL PHARMACOLOGY, 2002, 64 (5-6) : 963 - 970
  • [82] Regulation of secondary lymphoid organ development by the nuclear factor-κB signal transduction pathway
    Weih, F
    Caamaño, J
    [J]. IMMUNOLOGICAL REVIEWS, 2003, 195 : 91 - 105
  • [83] MULTIORGAN INFLAMMATION AND HEMATOPOIETIC ABNORMALITIES IN MICE WITH A TARGETED DISRUPTION OF RELB, A MEMBER OF THE NF-KAPPA-B/REL FAMILY
    WEIH, F
    CARRASCO, D
    DURHAM, SK
    BARTON, DS
    RIZZO, CA
    RYSECK, RP
    LIRA, SA
    BRAVO, R
    [J]. CELL, 1995, 80 (02) : 331 - 340
  • [84] Stimulus specificity of gene expression programs determined by temporal control of IKK activity
    Werner, SL
    Barken, D
    Hoffmann, A
    [J]. SCIENCE, 2005, 309 (5742) : 1857 - 1861
  • [85] WERNER SL, IN PRESS J CELL SCI
  • [86] De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
    Wertz, IE
    O'Rourke, KM
    Zhou, HL
    Eby, M
    Aravind, L
    Seshagiri, S
    Wu, P
    Wiesmann, C
    Baker, R
    Boone, DL
    Ma, A
    Koonin, EV
    Dixit, VM
    [J]. NATURE, 2004, 430 (7000) : 694 - 699
  • [87] Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway
    Yamamoto, M
    Sato, S
    Hemmi, H
    Hoshino, K
    Kaisho, T
    Sanjo, H
    Takeuchi, O
    Sugiyama, M
    Okabe, M
    Takeda, K
    Akira, S
    [J]. SCIENCE, 2003, 301 (5633) : 640 - 643
  • [88] RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF
    Yilmaz, ZB
    Weih, DS
    Sivakumar, V
    Weih, F
    [J]. EMBO JOURNAL, 2003, 22 (01) : 121 - 130
  • [89] PURIFIED HUMAN I-KAPPA-B CAN RAPIDLY DISSOCIATE THE COMPLEX OF THE NF-KAPPA-B TRANSCRIPTION FACTOR WITH ITS COGNATE DNA
    ZABEL, U
    BAEUERLE, PA
    [J]. CELL, 1990, 61 (02) : 255 - 265
  • [90] Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-κB activation pathways
    Zarnegar, B
    He, JQ
    Oganesyan, G
    Hoffmann, A
    Baltimore, D
    Cheng, GH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (21) : 8108 - 8113